Targeting STAT5A via CRISPR/Cas9 Restores TKI Sensitivity in Resistant Chronic Myeloid Leukemia Cells”

Conference paper > Full Text · 2025

Authors: Burçin KAYMAZ

12th Aegean Hematology Oncology Symposium, Türkiye, Antalya, International, Verbal, Full Text, 2025-2025, pp 7-10

View details